Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DNTH compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
DNTH
Dianthus Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
DNTH
Dianthus Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only DNTH
3
—
Nanjing Leads Biolabs
unlisted
supplier
—
IONTAS
unlisted
supplier
—
Tenacia Biotechnology (Hong Kong)
unlisted
customer
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›
DNTH
Dianthus Therapeutics, Inc.
Change
84.18
▲
+1.80%
Mkt cap
$4.6B
Revenue
$761,000
Q2 FY26
Revenue
$6M
FY24
LLY
ELI Lilly & Co
Change
1,417.69
▲
+0.59%
Regular session
Nov 4 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 4 '26
DNTH
Dianthus Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
84.18
▲
+1.80%
Price
1,417.69
▲
+0.59%
$4.6B
Mkt cap
$1.3T
Q2 FY26
$761,000
Revenue
$24.4B
Q3 FY26
FY24
$6M
Revenue
$65.2B
FY25
Change
Change
DNTH
84.18
▲
+1.80%
vs
LLY
1,417.69
▲
+0.59%
Regular session
Nov 4 '26